Filing Details
- Accession Number:
- 0001209191-18-029966
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-14 17:50:30
- Reporting Period:
- 2018-02-21
- Accepted Time:
- 2018-05-14 17:50:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1516479 | Insys Therapeutics Inc. | INSY | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1467848 | Brian Tambi | C/O Insys Therapeutics, Inc. 1333 South Spectrum Blvd, Suite 100 Chandler AZ 85286 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-02-21 | 4,000 | $0.00 | 4,000 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2018-05-10 | 33,654 | $0.61 | 37,654 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-05-10 | 68,850 | $1.62 | 106,504 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-05-10 | 60,000 | $3.63 | 166,504 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-05-10 | 166,504 | $6.41 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2018-02-21 | 4,000 | $0.00 | 4,000 | $0.00 |
| Common Stock | Stock Option (right to buy) | Disposition | 2018-05-10 | 33,654 | $0.00 | 33,654 | $0.61 |
| Common Stock | Stock Option (right to buy) | Disposition | 2018-05-10 | 68,850 | $0.00 | 68,850 | $1.62 |
| Common Stock | Stock Option (right to buy) | Disposition | 2018-05-10 | 60,000 | $0.00 | 60,000 | $3.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | D | Direct | ||
| 0 | 2020-02-21 | No | 4 | M | Direct | |
| 0 | 2021-03-28 | No | 4 | M | Direct | |
| 0 | 2023-05-13 | No | 4 | M | Direct |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.61 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- The restricted stock units ("RSUs") vested on the one year anniversary of the date of grant.
- The exercise price reflects a 3-for-2 forward stock split effected by the Issuer on March 28, 2014 and a 2-for-1 forward stock split effected by the Issuer on June 5, 2015.
- The option is fully vested and exercisable.
Billionaire Hedge Funds
